(Q74261278)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10971522%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Anti-topoisomerase II alpha autoantibodies in systemic sclerosis-association with pulmonary hypertension and HLA-B35 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10971522%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

main subject

pulmonary hypertension

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10971522%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

I Mazzetti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10971522%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

R Meliconi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10971522%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

S Bazzi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10971522%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

R Scorza

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10971522%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

M Candela

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10971522%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

A Gabrielli

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10971522%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

A Facchini

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10971522%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 September 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10971522%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10971522%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

121

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10971522%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10971522%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

539-543

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10971522%20AND%20SRC:MED&resulttype=core&format=json

Autoantibody to centromere (kinetochore) in scleroderma sera

9 November 2019

cites work

1 reference

12 December 2020

Identification of a nuclear protein (Scl-70) as a unique target of human antinuclear antibodies in scleroderma

1 reference

12 December 2020

DNA topoisomerases--enzymes that catalyse the breaking and rejoining of DNA.

1 reference

12 December 2020

Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide

1 reference

12 December 2020

Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: the target of the drugs is DNA.

1 reference

12 December 2020

Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients

1 reference

12 December 2020

Identification of DNA topoisomerase II as an intracellular target of antitumor epipodophyllotoxins in simian virus 40-infected monkey cells

1 reference

12 December 2020

Antinuclear antibodies in progressive systemic sclerosis

1 reference

12 December 2020

High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients

1 reference

12 December 2020

Altered DNA ligase I activity in Bloom's syndrome cells

1 reference

12 December 2020

Estrogen-induced potentiation of DNA damage and cytotoxicity in human breast cancer cells treated with topoisomerase II-interactive antitumor drugs

1 reference

12 December 2020

Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle

1 reference

12 December 2020

Scleroderma (systemic sclerosis): classification, subsets and pathogenesis

1 reference

12 December 2020

Human autoantibody to topoisomerase II.

1 reference

12 December 2020

Autoantibodies to DNA topoisomerase II in cryptogenic fibrosing alveolitis and connective tissue disease

1 reference

12 December 2020

Determination of an epitope of the diffuse systemic sclerosis marker antigen DNA topoisomerase I: sequence similarity with retroviral p30gag protein suggests a possible cause for autoimmunity in systemic sclerosis

1 reference

12 December 2020

Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II.

1 reference

12 December 2020

Autoantibodies to DNA topoisomerase II in juvenile rheumatoid arthritis

1 reference

12 December 2020

Monoclonal antibodies to human DNA topoisomerase I and the two isoforms of DNA topoisomerase II: 170- and 180-kDa isozymes

1 reference

12 December 2020

Autoantibody reactive with three classes of RNA polymerases in sera from patients with systemic sclerosis

1 reference

12 December 2020

Autoantibody reactive with RNA polymerase III in systemic sclerosis

1 reference

12 December 2020

Identification of a subset of patients with scleroderma with severe pulmonary and vascular disease by the presence of autoantibodies to centromere and histone

1 reference

12 December 2020

Antibodies to topoisomerase II in idiopathic pulmonary fibrosis

1 reference

12 December 2020

Antihistone antibodies in systemic sclerosis. Association with pulmonary fibrosis

1 reference

12 December 2020

Major histocompatibility complex class II and C4 alleles in Mexican Americans with systemic lupus erythematosus

1 reference

12 December 2020

Lack of association between antihistone antibodies and pulmonary fibrosis in patients with systemic sclerosis: comment on the article by sato et al

1 reference

12 December 2020

Characterization of human DNA topoisomerase II as an autoantigen recognized by patients with IDDM.

1 reference

12 December 2020

Primary pulmonary hypertension in HIV infection: an outcome determined by particular HLA class II alleles

1 reference

12 December 2020

Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis

1 reference

12 December 2020

Lung involvement in systemic sclerosis (scleroderma): relation to classification based on extent of skin involvement or autoantibody status

1 reference

12 December 2020

Comparison of different methods for the detection of autoantibodies in autoimmune diseases

1 reference

12 December 2020

Identification of autoantibodies to the I protein of the heterogeneous nuclear ribonucleoprotein complex in patients with systemic sclerosis

1 reference

12 December 2020

Primary pulmonary hypertension, tissue plasminogen activator antibodies, and HLA-DQ7

1 reference

12 December 2020

HLA and clinical associations in systemic sclerosis patients with anti-Th/To antibodies

1 reference

12 December 2020

Human immunodeficiency virus infection and pulmonary hypertension: two new cases and a review of 86 reported cases

1 reference

12 December 2020

Genetics and immunogenetic aspects of primary pulmonary hypertension

1 reference

12 December 2020

Mapping of topoisomerase II alpha epitopes recognized by autoantibodies in idiopathic pulmonary fibrosis

1 reference

12 December 2020

Primary pulmonary hypertension in a patient with HIV infection

1 reference

12 December 2020

Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody

1 reference

12 December 2020

Systemic sclerosis: an autoantibody mosaic

1 reference

12 December 2020

Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture

1 reference

12 December 2020

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee

1 reference

12 December 2020